News & views: anti-amyloid antibodies and novel emerging approaches to Alzheimer’s disease in 2023
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
News & views: anti-amyloid antibodies and novel emerging approaches to Alzheimer’s disease in 2023 ; volume:18 ; number:1 ; day:25 ; month:9 ; year:2023 ; pages:1-3 ; date:12.2023
Molecular neurodegeneration ; 18, Heft 1 (25.9.2023), 1-3, 12.2023
- Urheber
-
Gandy, Sam
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13024-023-00656-x
- URN
-
urn:nbn:de:101:1-2024020808553618604671
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gandy, Sam
- SpringerLink (Online service)
Ähnliche Objekte (12)
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer’s Disease
Views and Perceptions of Amyloid Imaging in a Preclinical Alzheimer’s Disease Trial
Anti-amyloid therapies for Alzheimer disease: finally, good news for patients
Amyloid PET imaging: applications beyond Alzheimer’s disease
Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Amyloid blood biomarker detects Alzheimer's disease
Copper binding to the Alzheimer’s disease amyloid precursor protein
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer’s Disease
Views and Perceptions of Amyloid Imaging in a Preclinical Alzheimer’s Disease Trial
Anti-amyloid therapies for Alzheimer disease: finally, good news for patients
Amyloid PET imaging: applications beyond Alzheimer’s disease
Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Amyloid blood biomarker detects Alzheimer's disease
Copper binding to the Alzheimer’s disease amyloid precursor protein
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer’s Disease
Views and Perceptions of Amyloid Imaging in a Preclinical Alzheimer’s Disease Trial
Anti-amyloid therapies for Alzheimer disease: finally, good news for patients
Amyloid PET imaging: applications beyond Alzheimer’s disease
Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Amyloid blood biomarker detects Alzheimer's disease
Copper binding to the Alzheimer’s disease amyloid precursor protein
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity